Moreover, this study provides the first molecular mechanism for enzymatically active LOXL2 in the promotion of cancer via its modification of a non-collagenous substrate in the context of paracrine signaling between tumor cells and resident fibroblasts. Here, LOXL2 is linked to cancer.